The performance of companies tied to the drug's past presents a intricate investment picture . While the initial boom generated substantial gains, generic competition have significantly eroded revenue. https://hypebookmarking.com/story21406209/copyright-s-flagship-product-and-big-pharma-a-uncertain-investment